On March 10, 2022, China National Medical Products Administration (NMPA) issued an announcement, answering frequently asked questions about ingredient safety information, efficacy claim evaluation and sample retention.
1. How to correctly submit cosmetic ingredient safety information when applying for registration or notification?
2. How to correctly understand cosmetic efficacy claim evaluation? What should be done for registered and notified products to comply with the regulatory requirements for cosmetic efficacy claim management?
3. How should cosmetic registrants and notifiers keep the samples of products? How to determine the quantity of retained samples?
4. Where should registrants and notifiers of imported cosmetics keep samples of their cosmetics imported into China?